Tag: cancer
-
Vitamin D doesn’t cut prostate cancer risk
Source Reuters U.S. National Cancer Institute researchers set out to see if vitamin D might protect against prostate cancer, the second most frequently diagnosed cancer in men worldwide. They tracked vitamin D concentrations in the blood of 749 men diagnosed with prostate cancer and 781 men who did not have the disease. They found no…
-
Surgical experience affects prostate cancer control ‘regardless of risk’
From MedWire News – Oncology – Prostate cancer control after radical prostatectomy improves with increasing surgeon experience, regardless of patients’ risk, say US scientists who suggest that the primary reason for recurrence in low-risk patients is inadequate surgical technique. The team, led by Eric Klein from the Cleveland Clinic in Ohio, previously discovered that open…
-
– Oncology – High saturated fat diet linked to postop biochemical failure
From MedWire News Among prostatectomy patients, those with diets high in high saturated fat (HSF) are almost twice as likely to experience biochemical failure as those who consume a low saturated fat (LSF) diet, say US scientists. Several studies have indicated that obesity is associated with an increased risk of biochemical failure after treatment with…
-
Newer Prostate Cancer Treatment Similar to Traditional Surgery
From Washington Post.com “This reaffirms what many other manuscripts have shown, if you go to an individual who has experience, who does this on a consistent basis, your outcomes will be better,” said Dr. Ihor S. Sawczuk, chief of urologic oncology for the Cancer Center at Hackensack University Medical Center, in New Jersey. “If you…
-
Clinical Outcomes after Sexuality Preserving Cystectomy and Neobladder (Prostate Sparing Cystectomy) in 44 Patients
nerve sparing cystectomy
-
Waiting Time From Initial Urological Consultation to Nephrectomy for Renal Cell Carcinoma-Does it Affect Survival?
From UroToday Surgical waiting time from initial urological consultation to operative intervention does not adversely affect the outcome of renal cell carcinoma within the time frames analyzed in this study, in which 94% of cases occurred within 3 months. Individual urologist judgment remains a critical factor in the appropriate and timely care of the patient…
-
Biomarker predicts malignancy potential of prostate lesions –
From Urology Times Spanish researchers have found a means of distinguishing between high-grade prostatic intraepithelial neoplasia (HGPIN) lesions destined to become cancerous and those that will remain benign, which may spare patients the discomfort and inconvenience of unnecessary needle biopsies, according to a study in Clinical Cancer Research (2008; 14:2617-22). This is the first studay…
-
A Step Backward: The ACPM Recommendations on Prostate Cancer Screening
Medscape article summarizing PSA recommendations: The most aggressive screening protocol is from the NCCN. NCCN guidelines start from the premise that the patient has made a decision to seek early prostate cancer detection. They recommend beginning screening at age 40. The baseline PSA level, race, and family history are then used to determine the subsequent…
-
IMRT external beam radiation review
UroToday – Current Status of Intensity-Modulated Radiation Therapy (IMRT) In the International Journal of Clinical Oncology, Dr. Hatano and colleagues from Chiba, Japan provide an excellent overview of intensity-modulated radiation therapy (IMRT). Problems with conventional, four field radiotherapy have been ineffective dose distribution and overdoses to organs at risk (OARs), such as the bladder and…